Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2022.2081417
Abstract: Abstract Aims To compare long-term healthcare resource utilization (HCRU) and costs among patients who initiated ixekizumab (IXE) or adalimumab (ADA) for treatment of psoriasis in the United States. Methods Adult patients with psoriasis who had… read more here.
Keywords: ada users; ixe ada; healthcare resource; resource utilization ... See more keywords
National Trends in Out-of-Pocket Costs Among U.S. Adults With Diabetes Aged 18–64 Years: 2001–2017
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes Care"
DOI: 10.2337/dc20-2833
Abstract: OBJECTIVE To assess national trends in out-of-pocket (OOP) costs among adults aged 18–64 years with diabetes in the U.S. RESEARCH DESIGN AND METHODS Using data from the 2001–2017 Medical Expenditure Panel Survey, we estimated total… read more here.
Keywords: oop; insurance; oop costs; national trends ... See more keywords